Ads
related to: $35 asthma inhalersdoconsumer.com has been visited by 100K+ users in the past month
sidekickbird.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Following years of public outcry about the high cost of inhalers, the two drugmakers — along with a third, GlaxoSmithKline — have committed to capping the out-of-pocket cost at $35 a month.
Boehringer had also said it would cap out-of-pocket costs for its inhaler products for chronic lung disease and asthma to $35 per month, starting June 1. ... including inhalers to treat asthma and ...
(Reuters) - Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German drugmaker ...
It is available as an inhaler, cream, pills, and nasal spray. [2] The inhaled form is used in the long-term management of asthma. [1] The cream may be used for dermatitis and psoriasis. [3] The pills have been used to treat ulcerative colitis. [4] The nasal spray is used to treat allergic rhinitis and nasal polyps. [5]
$35.4 exemestane: Aromasin Breast cancer Pfizer: $465 $401 $320 $247 $143 $58 ... Asthma Merck: $4,336.9 $4,266.3 $3,579 $2,975.6 $2,622 alendronate sodium: Fosamax
3M made $35.4 billion in total sales in 2021 and ranked number 102 in the Fortune 500 list of the largest United States corporations by total revenue. [10] As of 2021, the company had approximately 95,000 employees and operations in more than 70 countries. [11] There are a few international subsidiaries, such as 3M India, 3M Japan, and 3M Canada.
Ads
related to: $35 asthma inhalersdoconsumer.com has been visited by 100K+ users in the past month
sidekickbird.com has been visited by 100K+ users in the past month